The future of AI and precision medicine in optometry
John Marhsall will outline the necessity for precision digital medicine and highlight the significance of 100% Optical as a platform for unveiling scientific advancements in optometry.
He will introduce "Toku Inc" as a trailblazer in the ophthalmic industry, known for its unwavering commitment to scientific advancements and emphasise Toku's approach, rooted in scientific research and development, which has led to pioneering breakthroughs in the field.
There will be a discussion about the scientific significance of Toku's BioAge product, explaining how it leverages cutting-edge science to revolutionise eye care and he will highlight “BioAge“ which represents a precursor to CLAiR, Toku's forthcoming product, which also promises to deliver ground-breaking scientific solutions.
The importance of workflow for AI in optometry including harmony integration will also be showcased.
Finally, a look at what’s next for Toku (CKD, HT ) and what’s next for the industry regarding precision digital medicine, and where partnerships can leverage gain for patient outcome.
![topcon](https://cdn.asp.events/CLIENT_Media_10_B9D470DF_5056_B739_5443B4BBAA6F8ED4/sites/100-Optical/media/Topcon_Healthcare_vt_rgb-(2).jpg)